Margaret Bevans

992 total citations
21 papers, 568 citations indexed

About

Margaret Bevans is a scholar working on Surgery, Neurology and Epidemiology. According to data from OpenAlex, Margaret Bevans has authored 21 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Neurology and 3 papers in Epidemiology. Recurrent topics in Margaret Bevans's work include Liver Disease Diagnosis and Treatment (3 papers), Cardiovascular Conditions and Treatments (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Margaret Bevans is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Cardiovascular Conditions and Treatments (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Margaret Bevans collaborates with scholars based in United States. Margaret Bevans's co-authors include Felix E. Demartini, Charles Ragan, Judith Nadell, Beatrice Carrier Seegal, E.H. Mosbach, Arthur J. Patek, David Seegal, Ruth Kaplan, Mary Richardson and Laura L. Read and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and American Journal of Psychiatry.

In The Last Decade

Margaret Bevans

20 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret Bevans United States 13 110 90 86 73 73 21 568
A J Fairfax United Kingdom 13 136 1.2× 89 1.0× 44 0.5× 166 2.3× 110 1.5× 20 607
I Caubarrère France 10 155 1.4× 80 0.9× 48 0.6× 171 2.3× 81 1.1× 44 521
W. S. Blakemore United States 11 66 0.6× 24 0.3× 92 1.1× 109 1.5× 108 1.5× 21 545
Gabriel Spergel United States 11 87 0.8× 24 0.3× 74 0.9× 96 1.3× 107 1.5× 18 507
A G Riddell United Kingdom 13 134 1.2× 31 0.3× 43 0.5× 60 0.8× 182 2.5× 33 554
T Okanoue Japan 6 171 1.6× 113 1.3× 43 0.5× 37 0.5× 55 0.8× 10 534
L. Diekmann Germany 14 95 0.9× 53 0.6× 62 0.7× 121 1.7× 40 0.5× 60 580
O.E. Eade United Kingdom 14 227 2.1× 37 0.4× 29 0.3× 78 1.1× 213 2.9× 27 663
A Cirelli Italy 12 130 1.2× 89 1.0× 39 0.5× 16 0.2× 52 0.7× 24 699
Marie‐Claude Lescs France 11 131 1.2× 84 0.9× 115 1.3× 86 1.2× 75 1.0× 12 623

Countries citing papers authored by Margaret Bevans

Since Specialization
Citations

This map shows the geographic impact of Margaret Bevans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Bevans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Bevans more than expected).

Fields of papers citing papers by Margaret Bevans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Bevans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Bevans. The network helps show where Margaret Bevans may publish in the future.

Co-authorship network of co-authors of Margaret Bevans

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Bevans. A scholar is included among the top collaborators of Margaret Bevans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Bevans. Margaret Bevans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Polizzotto, Mark N., Thomas S. Uldrick, Kathleen M. Wyvill, et al.. (2016). Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study. Journal of Clinical Oncology. 34(34). 4125–4131. 86 indexed citations
2.
Richardson, Mary, Margaret Bevans, Laura L. Read, et al.. (2003). Efficacy of the Branched-Chain Amino Acids in the Treatment of Tardive Dyskinesia in Men. American Journal of Psychiatry. 160(6). 1117–1124. 41 indexed citations
3.
Richardson, Mary, et al.. (1999). Branched chain amino acids decrease tardive dyskinesia symptoms. Psychopharmacology. 143(4). 358–364. 27 indexed citations
4.
Richardson, Mary, et al.. (1997). TD symptom decreases with regulation of plasma large neutral amino acids. Schizophrenia Research. 24(1-2). 272–272. 1 indexed citations
5.
Patek, A. J., et al.. (1960). Recovery from dietary cirrhosis of the liver in the rat; changes in hepatic collagen and in microscopic appearance.. PubMed. 69. 168–74. 8 indexed citations
6.
Bevans, Margaret, et al.. (1960). Early pathologic and biochemical changes in rabbits fed dihydrocholesterol.. PubMed. 37. 631–9. 7 indexed citations
7.
Deming, Quentin B., E.H. Mosbach, Margaret Bevans, et al.. (1958). BLOOD PRESSURE, CHOLESTEROL CONTENT OF SERUM AND TISSUES, AND ATHEROGENESIS IN THE RAT. The Journal of Experimental Medicine. 107(4). 581–598. 59 indexed citations
8.
Seegal, Beatrice Carrier & Margaret Bevans. (1957). The production of glomerulonephritis by immunologic methods. Journal of Chronic Diseases. 5(1). 153–172. 26 indexed citations
9.
Bevans, Margaret, et al.. (1957). Immediate or delayed nephritis in rats produced by duck anti-rat-kidney sera.. PubMed. 64(2). 192–204. 15 indexed citations
10.
Mosbach, E.H. & Margaret Bevans. (1956). Formation of gall stones in rabbits fed 3β-cholestanol. Archives of Biochemistry and Biophysics. 63(1). 258–259. 10 indexed citations
11.
Bevans, Margaret & E.H. Mosbach. (1956). Biological studies of dihydrocholesterol; production of biliary concrements and inflammatory lesions of the biliary tract in rabbits.. PubMed. 62(2). 112–7. 12 indexed citations
12.
Bevans, Margaret. (1955). Atherosclerotic Lesions in Diabetes. Diabetes. 4(4). 259–264. 2 indexed citations
13.
Bevans, Margaret, Beatrice Carrier Seegal, & Ruth Kaplan. (1955). GLOMERULONEPHRITIS PRODUCED IN DOGS BY SPECIFIC ANTISERA. The Journal of Experimental Medicine. 102(6). 807–822. 27 indexed citations
14.
Bevans, Margaret, Judith Nadell, Felix E. Demartini, & Charles Ragan. (1954). The systemic lesions of malignant rheumatoid arthritis. The American Journal of Medicine. 16(2). 197–211. 121 indexed citations
15.
Patek, Arthur J., Irvin C. Plough, & Margaret Bevans. (1954). RELATIVE EFFECTS OF PROTEIN AND LIPOTROPIC SUBSTANCES IN THE TREATMENT OF NUTRITIONAL CIRRHOSIS IN RATS. Annals of the New York Academy of Sciences. 57(6). 772–775. 3 indexed citations
16.
Plough, Irvin C., Arthur J. Patek, & Margaret Bevans. (1952). THE RELATIVE EFFECTS OF PROTEIN, CHOLINE, AND METHIONINE IN THE TREATMENT OF EXPERIMENTAL DIETARY CIRRHOSIS IN THE RAT. The Journal of Experimental Medicine. 96(3). 221–231. 13 indexed citations
17.
Howard, Robert, et al.. (1951). CORTISONE THERAPY IN CASE OF RHEUMATOID NODULES OF THE EYE IN CHRONIC RHEUMATOID ARTHRITIS. Archives of Ophthalmology. 45(5). 531–538. 25 indexed citations
18.
Bevans, Margaret, et al.. (1951). The early lesions of canine arteriosclerosis.. PubMed. 51(3). 278–87. 14 indexed citations
19.
Bevans, Margaret, et al.. (1951). Regression of lesions in canine arteriosclerosis.. PubMed. 51(3). 288–92. 38 indexed citations
20.
Patek, Arthur J., David Seegal, & Margaret Bevans. (1951). THE COEXISTENCE OF CIRRHOSIS OF THE LIVER AND GLOMERULONEPHRITIS. The American Journal of the Medical Sciences. 221(1). 77–85. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A J Fairfax Breakdown of academic impact, for papers by I Caubarrère Breakdown of academic impact, for papers by W. S. Blakemore Breakdown of academic impact, for papers by Gabriel Spergel Breakdown of academic impact, for papers by A G Riddell Breakdown of academic impact, for papers by T Okanoue Breakdown of academic impact, for papers by L. Diekmann Breakdown of academic impact, for papers by O.E. Eade Breakdown of academic impact, for papers by A Cirelli Breakdown of academic impact, for papers by Marie‐Claude Lescs
Rankless by CCL
2026